🔴 Nasus Pharma is trading 5% down today with no clear company-specific catalyst identified

Nasus Pharma is trading at $3.28, down 5.07%, with no clear company-specific announcement identified for August 10, 2026.

• The June 9 NS003 preclinical update predates the decline and does not explain it.
• Trading volume was 9.36K, below the 16.94K average daily volume.
• Broader markets were mixed while healthcare gained, offering no clear sector or macro explanation.